19648605

Source:http://linkedlifedata.com/resource/pubmed/id/19648605

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001792, umls-concept:C0008976, umls-concept:C0018801, umls-concept:C0030705, umls-concept:C0036043, umls-concept:C0068475, umls-concept:C0233820, umls-concept:C0341697, umls-concept:C1456594
pubmed:issue	9
pubmed:dateCreated	2009-8-21
pubmed:abstractText	To determine the safety and efficacy of nebivolol in elderly heart failure (HF) patients with renal dysfunction.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-10393685, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-10716471, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-11216954, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-11331052, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-11511434, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-11583864, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-12089390, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-12223176, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-15489090, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-15596637, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-15642700, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-15680267, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-15808129, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-16084759, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-16183692, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-16461840, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-16924166, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-16949463, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-17000947, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-17015793, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-17105890, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-17393304, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-17584562, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-17586090, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-18325437, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-18378519, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-18755344, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-18826876, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-19106198, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-19398079, http://linkedlifedata.com/resource/pubmed/commentcorrection/19648605-19497441
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100887595
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Benzopyrans, http://linkedlifedata.com/resource/pubmed/chemical/Creatinine, http://linkedlifedata.com/resource/pubmed/chemical/Ethanolamines, http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents, http://linkedlifedata.com/resource/pubmed/chemical/nebivolol
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	1879-0844
pubmed:author	pubmed-author:BöhmMichaelM, pubmed-author:BabalisDaphneD, pubmed-author:CoatsAndrew JAJ, pubmed-author:Cohen-SolalAlainA, pubmed-author:FlatherMarcusM, pubmed-author:KotechaDipakD, pubmed-author:Poole-WilsonPhilipP, pubmed-author:RoughtonMichaelM, pubmed-author:SENIORS Investigators, pubmed-author:TavazziLuigiL, pubmed-author:van VeldhuisenDirk JDJ
pubmed:issnType	Electronic
pubmed:volume	11
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	872-80
pubmed:dateRevised	2011-6-8
pubmed:meshHeading	pubmed-meshheading:19648605-Adrenergic beta-Antagonists, pubmed-meshheading:19648605-Age Factors, pubmed-meshheading:19648605-Aged, pubmed-meshheading:19648605-Aged, 80 and over, pubmed-meshheading:19648605-Analysis of Variance, pubmed-meshheading:19648605-Benzopyrans, pubmed-meshheading:19648605-Confidence Intervals, pubmed-meshheading:19648605-Creatinine, pubmed-meshheading:19648605-Ethanolamines, pubmed-meshheading:19648605-Female, pubmed-meshheading:19648605-Glomerular Filtration Rate, pubmed-meshheading:19648605-Heart Rate, pubmed-meshheading:19648605-Humans, pubmed-meshheading:19648605-Kidney, pubmed-meshheading:19648605-Kidney Diseases, pubmed-meshheading:19648605-Male, pubmed-meshheading:19648605-Multivariate Analysis, pubmed-meshheading:19648605-Stroke Volume, pubmed-meshheading:19648605-Vasodilator Agents, pubmed-meshheading:19648605-Ventricular Function, Left
pubmed:year	2009
pubmed:articleTitle	Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial.
pubmed:affiliation	Hôpital Lariboisiere, Assistance Publique-Hopitaux de Paris, Université Paris Diderot, INSERM U942, 2 Rue Ambroise Paré, 75475 Paris Cedex 10, France.
pubmed:publicationType	Journal Article, Randomized Controlled Trial